CLH consultation launched on Penconazole

On 22 August 2022, ECHA started a 60 day public commenting period on the Harmonised Classification and Labelling (CLH) proposals for the following substance:

  1. Penconazole

Previous
Previous

2-tert-butyl-4-methoxyphenol added to Endocrine Disruptor Assessment List

Next
Next

Canada DSL updated